Triglyceridspeicherkrankheit mit Myopathie ist eine autosomal rezessive Erkrankung, die durch Mutationen des PNPLA2-Gens ausgelöst wird.
![]() |
||||
![]() |
![]() |
|||
![]() |
![]() |
|||
![]() |
![]() |
![]() ![]() |
||
![]() |
![]() |
![]() |
![]() |
![]() |
1. |
Fischer J et al. (2007) The gene encoding adipose triglyceride lipase (PNPLA2) is mutated in neutral lipid storage disease with myopathy. ![]() |
2. |
Akiyama M et al. (2007) Novel duplication mutation in the patatin domain of adipose triglyceride lipase (PNPLA2) in neutral lipid storage disease with severe myopathy. ![]() |
3. |
Reilich P et al. (2011) The phenotypic spectrum of neutral lipid storage myopathy due to mutations in the PNPLA2 gene. ![]() |
4. |
Lin P et al. (2012) Novel PNPLA2 gene mutations in Chinese Han patients causing neutral lipid storage disease with myopathy. ![]() |
5. |
Janssen MC et al. (2013) Symptomatic lipid storage in carriers for the PNPLA2 gene. ![]() |
6. |
OMIM.ORG article Omim 610717![]() |
7. |
Orphanet article Orphanet ID 98908![]() |